Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 24, Number 2—February 2018
Research

New Parvovirus Associated with Serum Hepatitis in Horses after Inoculation of Common Biological Product

Thomas J. Divers, Bud C. Tennant1, Arvind Kumar, Sean McDonough, John Cullen, Nishit Bhuva, Komal Jain, Lokendra Singh Chauhan, Troels Kasper Høyer Scheel, W. Ian Lipkin, Melissa Laverack, Sheetal Trivedi, Satyapramod Srinivasa, Laurie Beard, Charles M. Rice, Peter D. Burbelo, Randall W. Renshaw, Edward Dubovi, and Amit KapoorComments to Author 
Author affiliations: Cornell University, Ithaca, New York, USA (T.J. Divers, B.C. Tennant, S. McDonough, M. Laverack, R.W. Renshaw, E. Dubovi); Nationwide Children’s Hospital, Columbus, Ohio, USA (A. Kumar, S. Trivedi, S. Srinivasa, A. Kapoor); North Carolina State University, Raleigh, North Carolina, USA (J. Cullen); Columbia University, New York, New York, USA (N. Bhuva, K. Jain, L.S. Chauhan, W.I. Lipkin); University of Copenhagen, Copenhagen, Denmark (T.K.H. Scheel); Hvidovre Hospital, Copenhagen (T.K.H. Scheel); Rockefeller University, New York (T.K.H. Scheel, C.M. Rice); Kansas State University, Manhattan, Kansas, USA (L. Beard); National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland, USA (P.D. Burbelo)

Main Article

Figure 2

EqPV-H DNA secondary structure of the 503-nt long intergenic region predicted using mFOLD (25). EqPV-H, equine parvovirus hepatitis.

Figure 2. EqPV-H DNA secondary structure of the 583-nt intergenic region predicted using mFOLD (25). EqPV-H, equine parvovirus hepatitis.

Main Article

References
  1. Theiler  A. Acute liver atrophy and parenchymatous hepatitis in horses. Reports of the Director of Veterinary Research. 1918;5&6:7–99.
  2. Marsh  H. Losses of undetermined cause following an outbreak of equine encephalomyelitis. J Am Vet Med Assoc. 1937;91:88–93.
  3. Hjerpe  CA. Serum hepatitis in the horse. J Am Vet Med Assoc. 1964;144:734–40.PubMedGoogle Scholar
  4. Rose  JA, Immenschuh  RD, Rose  EM. Serum hepatitis in the horse. Proceedings of the Twentieth Annual Conference of the American Association of Equine Practitioners. Lexington (KY): American Association of Equine Practitioners; 1974. p. 175–85.
  5. Thomsett  LR. Acute hepatic failure in the horse. Equine Vet J. 1971;3:15–9. DOIPubMedGoogle Scholar
  6. Step  DL, Blue  JT, Dill  SG. Penicillin-induced hemolytic anemia and acute hepatic failure following treatment of tetanus in a horse. Cornell Vet. 1991;81:13–8.PubMedGoogle Scholar
  7. Messer  NT IV, Johnson  PJ. Idiopathic acute hepatic disease in horses: 12 cases (1982-1992). J Am Vet Med Assoc. 1994;204:1934–7.PubMedGoogle Scholar
  8. Guglick  MA, MacAllister  CG, Ely  RW, Edwards  WC. Hepatic disease associated with administration of tetanus antitoxin in eight horses. J Am Vet Med Assoc. 1995;206:1737–40.PubMedGoogle Scholar
  9. Chandriani  S, Skewes-Cox  P, Zhong  W, Ganem  DE, Divers  TJ, Van Blaricum  AJ, et al. Identification of a previously undescribed divergent virus from the Flaviviridae family in an outbreak of equine serum hepatitis. Proc Natl Acad Sci U S A. 2013;110:E1407–15. DOIPubMedGoogle Scholar
  10. Panciera  RJ. Serum hepatitis in the horse. J Am Vet Med Assoc. 1969;155:408–10.PubMedGoogle Scholar
  11. Aleman  M, Nieto  JE, Carr  EA, Carlson  GP. Serum hepatitis associated with commercial plasma transfusion in horses. J Vet Intern Med. 2005;19:120–2. DOIPubMedGoogle Scholar
  12. Burbelo  PD, Dubovi  EJ, Simmonds  P, Medina  JL, Henriquez  JA, Mishra  N, et al. Serology-enabled discovery of genetically diverse hepaciviruses in a new host. J Virol. 2012;86:6171–8. DOIPubMedGoogle Scholar
  13. Kapoor  A, Simmonds  P, Cullen  JM, Scheel  TK, Medina  JL, Giannitti  F, et al. Identification of a pegivirus (GB virus-like virus) that infects horses. J Virol. 2013;87:7185–90. DOIPubMedGoogle Scholar
  14. Scheel  TK, Simmonds  P, Kapoor  A. Surveying the global virome: identification and characterization of HCV-related animal hepaciviruses. Antiviral Res. 2015;115:83–93. DOIPubMedGoogle Scholar
  15. Pfaender  S, Cavalleri  JM, Walter  S, Doerrbecker  J, Campana  B, Brown  RJ, et al. Clinical course of infection and viral tissue tropism of hepatitis C virus-like nonprimate hepaciviruses in horses. Hepatology. 2015;61:447–59. DOIPubMedGoogle Scholar
  16. Scheel  TK, Kapoor  A, Nishiuchi  E, Brock  KV, Yu  Y, Andrus  L, et al. Characterization of nonprimate hepacivirus and construction of a functional molecular clone. Proc Natl Acad Sci U S A. 2015;112:2192–7. DOIPubMedGoogle Scholar
  17. Ramsay  JD, Evanoff  R, Wilkinson  TE Jr, Divers  TJ, Knowles  DP, Mealey  RH. Experimental transmission of equine hepacivirus in horses as a model for hepatitis C virus. Hepatology. 2015;61:1533–46. DOIPubMedGoogle Scholar
  18. Lyons  S, Kapoor  A, Schneider  BS, Wolfe  ND, Culshaw  G, Corcoran  B, et al. Viraemic frequencies and seroprevalence of non-primate hepacivirus and equine pegiviruses in horses and other mammalian species. J Gen Virol. 2014;95:1701–11. DOIPubMedGoogle Scholar
  19. Kapoor  A, Kumar  A, Simmonds  P, Bhuva  N, Singh Chauhan  L, Lee  B, et al. Virome analysis of transfusion recipients reveals a novel human virus that shares genomic features with hepaciviruses and pegiviruses. MBio. 2015;6:e01466–15. DOIPubMedGoogle Scholar
  20. Kapoor  A, Hornig  M, Asokan  A, Williams  B, Henriquez  JA, Lipkin  WI. Bocavirus episome in infected human tissue contains non-identical termini. PLoS One. 2011;6:e21362. DOIPubMedGoogle Scholar
  21. Kapoor  A, Mehta  N, Dubovi  EJ, Simmonds  P, Govindasamy  L, Medina  JL, et al. Characterization of novel canine bocaviruses and their association with respiratory disease. J Gen Virol. 2012;93:341–6. DOIPubMedGoogle Scholar
  22. Kapoor  A, Mehta  N, Esper  F, Poljsak-Prijatelj  M, Quan  PL, Qaisar  N, et al. Identification and characterization of a new bocavirus species in gorillas. PLoS One. 2010;5:e11948. DOIPubMedGoogle Scholar
  23. Kapoor  A, Lipkin  WI. Virus discovery in the 21st century. Chichester (UK): John Wiley & Sons; 2014. DOIGoogle Scholar
  24. Tamura  K, Stecher  G, Peterson  D, Filipski  A, Kumar  S. MEGA6: Molecular Evolutionary Genetics Analysis version 6.0. Mol Biol Evol. 2013;30:2725–9. DOIPubMedGoogle Scholar
  25. Zuker  M. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res. 2003;31:3406–15. DOIPubMedGoogle Scholar
  26. Burbelo  PD, Ragheb  JA, Kapoor  A, Zhang  Y. The serological evidence in humans supports a negligible risk of zoonotic infection from porcine circovirus type 2. Biologicals. 2013;41:430–4. DOIPubMedGoogle Scholar
  27. Burbelo  PD, Ching  KH, Morse  CG, Alevizos  I, Bayat  A, Cohen  JI, et al. Altered antibody profiles against common infectious agents in chronic disease. PLoS One. 2013;8:e81635. DOIPubMedGoogle Scholar
  28. Burbelo  PD, Ching  KH, Esper  F, Iadarola  MJ, Delwart  E, Lipkin  WI, et al. Serological studies confirm the novel astrovirus HMOAstV-C as a highly prevalent human infectious agent. PLoS One. 2011;6:e22576. DOIPubMedGoogle Scholar
  29. Hartlage  AS, Cullen  JM, Kapoor  A. The strange, expanding world of animal hepaciviruses. Annu Rev Virol. 2016;3:53–75. DOIPubMedGoogle Scholar
  30. Kapoor  A, Simmonds  P, Dubovi  EJ, Qaisar  N, Henriquez  JA, Medina  J, et al. Characterization of a canine homolog of human Aichivirus. J Virol. 2011;85:11520–5. DOIPubMedGoogle Scholar
  31. Li  L, Giannitti  F, Low  J, Keyes  C, Ullmann  LS, Deng  X, et al. Exploring the virome of diseased horses. J Gen Virol. 2015;96:2721–33. DOIPubMedGoogle Scholar
  32. Kailasan  S, Agbandje-McKenna  M, Parrish  CR. Parvovirus family conundrum: what makes a killer? Annu Rev Virol. 2015;2:425–50. DOIPubMedGoogle Scholar
  33. Bihari  C, Rastogi  A, Saxena  P, Rangegowda  D, Chowdhury  A, Gupta  N, et al. Parvovirus B19 associated hepatitis. Hepat Res Treat. 2013;2013:472027.
  34. Hatakka  A, Klein  J, He  R, Piper  J, Tam  E, Walkty  A. Acute hepatitis as a manifestation of parvovirus B19 infection. J Clin Microbiol. 2011;49:3422–4. DOIPubMedGoogle Scholar
  35. Caruso  C, Gobbi  E, Biosa  T, Andra’  M, Cavallazzi  U, Masoero  L. Evaluation of viral inactivation of pseudorabies virus, encephalomyocarditis virus, bovine viral diarrhea virus and porcine parvovirus in pancreatin of porcine origin. J Virol Methods. 2014;208:79–84. DOIPubMedGoogle Scholar
  36. Roberts  PL, Hart  H. Comparison of the inactivation of canine and bovine parvovirus by freeze-drying and dry-heat treatment in two high purity factor VIII concentrates. Biologicals. 2000;28:185–8. DOIPubMedGoogle Scholar
  37. Mani  B, Gerber  M, Lieby  P, Boschetti  N, Kempf  C, Ros  C. Molecular mechanism underlying B19 virus inactivation and comparison to other parvoviruses. Transfusion. 2007;47:1765–74. DOIPubMedGoogle Scholar
  38. Blümel  J, Stühler  A, Dichtelmüller  H. Kinetics of inactivating human parvovirus B19 and porcine parvovirus by dry-heat treatment. Transfusion. 2008;48:790–1. DOIPubMedGoogle Scholar
  39. Qualls  CW, Gribble  DH. Equine serum hepatitis: a morphologic study. Lab Invest. 1976;34:330.
  40. Robinson  M, Gopinath  C, Hughes  DL. Histopathology of acute hepatitis in the horse. J Comp Pathol. 1975;85:111–8. DOIPubMedGoogle Scholar

Main Article

1Deceased.

Page created: January 17, 2018
Page updated: January 17, 2018
Page reviewed: January 17, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external